Induction of an IFN-mediated antiviral response by a self-amplifying RNA vaccine: implications for vaccine design

Cited by (208)

Items 201–208 of 208

1. mRNA cancer vaccines: delivery strategies, immune modulation, and clinical translation
   Dianzhe Tian, Xinshi Li, Zuyi Yang, Xinyu Zhao, Zixuan Hu, Haitao Zhao, Shunda Du, Sheng-Zhi Liu, Li Zhang, Yiyao Xu et al. · 2026 · Frontiers in Pharmacology
2. Capless self-amplifying mRNA vaccine induces dose-sparing protective immunity against HPAI clade 2.3.4.4 H5 virus in mice
   Beom Kyu Kim, Ji-Hyun Park, Won-Suk Choi, Sol Oh, Se Hee An, Gi Chan Lee, Santosh Chokkakula, Chang-Ung Kim, Ju Hwan Jeong, Seong Cheol Min et al. · 2026 · Molecular Therapy
3. Neoantigen nanovaccines for cancer immunotherapy: design strategies, translational bottlenecks, and clinical prospects
   Mengqi Sun, Liang Xiao, Yongqiang Yu · 2026 · Journal of Nanobiotechnology
4. Nanotechnology-based self-amplifying RNA
   Qinyu Deng, Hengbing Zhou, Senfeng Zhao, Jiajun Zhu, Zeyuan Xie, Linli Li, Yichang Xu, Yining Huang, Peiyan Dong, Tian Cao et al. · 2026 · iPharma
5. UNITE® Technology: Translating lysosomal targeting vaccines for allergy therapy
   Wei Shen, Teri Heiland · 2026 · Allergology International
6. Spatiotemporal control of STING activation and saRNA delivery decouples humoral and cellular immunity
   David J. Peeler, Ziyin Wang, Livia Spiga, Simbarashe Jokonya, Thomas Chubicka, Daniel Reumann, Katsiaryna Shramko, Laia Rigat Nogareda, Paul F. McKay, Dinh Chuong Nguyen et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
7. mRNA lipid nanoparticle vaccines: current status, challenges and future prospects
   吴志能, Jinghu Lou, Yi Cheng, Meng Li, Zengming Wang, Nan Liu, Xiang Gao, Aiping Zheng, Hui Zhang · 2026 · Molecular Biomedicine
8. Self-Amplifying RNA Vaccines After the First Approvals: Technology, Development Landscape, and Regulatory Science Considerations
   Sunghyun Yi, Eunhye Seo, Kee‐Jong Hong, Pil‐Gu Park · 2026 · International Journal of Molecular Sciences